BMRN Annual Gross Profit
$1.90 B
+$292.00 M+18.11%
31 December 2023
Summary:
As of January 20, 2025, BMRN annual gross profit is $1.90 billion, with the most recent change of +$292.00 million (+18.11%) on December 31, 2023. During the last 3 years, it has risen by +$568.19 million (+42.52%). BMRN annual gross profit is now at all-time high.BMRN Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Quarterly Gross Profit
$557.28 M
-$24.29 M-4.18%
30 September 2024
Summary:
As of January 20, 2025, BMRN quarterly gross profit is $557.28 million, with the most recent change of -$24.29 million (-4.18%) on September 30, 2024. Over the past year, it has increased by +$31.80 million (+6.05%). BMRN quarterly gross profit is now -4.18% below its all-time high of $581.57 million, reached on June 30, 2024.BMRN Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN TTM Gross Profit
$2.19 B
+$104.00 M+4.99%
30 September 2024
Summary:
As of January 20, 2025, BMRN TTM gross profit is $2.19 billion, with the most recent change of +$104.00 million (+4.99%) on September 30, 2024. Over the past year, it has increased by +$283.62 million (+14.89%). BMRN TTM gross profit is now at all-time high.BMRN TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.1% | +6.0% | +14.9% |
| 3 y3 years | +42.5% | +20.9% | +30.9% |
| 5 y5 years | +61.9% | +20.9% | +30.9% |
BMRN Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.4% | -4.2% | +68.8% | at high | +59.0% |
| 5 y | 5-year | at high | +42.5% | -4.2% | +93.5% | at high | +66.8% |
| alltime | all time | at high | >+9999.0% | -4.2% | >+9999.0% | at high | >+9999.0% |
BioMarin Pharmaceutical Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $557.28 M(-4.2%) | $2.19 B(+5.0%) |
| June 2024 | - | $581.57 M(+11.1%) | $2.08 B(+5.9%) |
| Mar 2024 | - | $523.65 M(-0.3%) | $1.97 B(+3.3%) |
| Dec 2023 | $1.90 B(+18.1%) | $525.49 M(+15.9%) | $1.90 B(+6.4%) |
| Sept 2023 | - | $453.29 M(-2.4%) | $1.79 B(+3.7%) |
| June 2023 | - | $464.66 M(+0.8%) | $1.72 B(+3.2%) |
| Mar 2023 | - | $460.94 M(+12.4%) | $1.67 B(+3.6%) |
| Dec 2022 | $1.61 B(+17.2%) | $410.25 M(+5.4%) | $1.61 B(+5.2%) |
| Sept 2022 | - | $389.06 M(-5.3%) | $1.53 B(+5.8%) |
| June 2022 | - | $410.67 M(+2.1%) | $1.45 B(+2.6%) |
| Mar 2022 | - | $402.39 M(+21.9%) | $1.41 B(+2.7%) |
| Dec 2021 | $1.38 B(+3.0%) | $330.06 M(+8.1%) | $1.38 B(+0.3%) |
| Sept 2021 | - | $305.20 M(-18.5%) | $1.37 B(+1.3%) |
| June 2021 | - | $374.63 M(+2.4%) | $1.35 B(+3.3%) |
| Mar 2021 | - | $365.86 M(+12.2%) | $1.31 B(-1.9%) |
| Dec 2020 | $1.34 B(-0.6%) | $325.98 M(+13.2%) | $1.34 B(-2.4%) |
| Sept 2020 | - | $287.99 M(-13.1%) | $1.37 B(-5.3%) |
| June 2020 | - | $331.52 M(-15.1%) | $1.44 B(+1.5%) |
| Mar 2020 | - | $390.67 M(+9.0%) | $1.42 B(+5.9%) |
| Dec 2019 | $1.34 B(+14.3%) | $358.54 M(-1.5%) | $1.34 B(+6.4%) |
| Sept 2019 | - | $364.15 M(+17.3%) | $1.26 B(+4.2%) |
| June 2019 | - | $310.33 M(-0.4%) | $1.21 B(+1.4%) |
| Mar 2019 | - | $311.56 M(+12.0%) | $1.20 B(+1.7%) |
| Dec 2018 | $1.18 B(+9.7%) | $278.24 M(-11.1%) | $1.18 B(-0.3%) |
| Sept 2018 | - | $312.81 M(+6.5%) | $1.18 B(+3.3%) |
| June 2018 | - | $293.83 M(+0.9%) | $1.14 B(+2.9%) |
| Mar 2018 | - | $291.11 M(+3.1%) | $1.11 B(+3.5%) |
| Dec 2017 | $1.07 B(+18.1%) | $282.31 M(+2.8%) | $1.07 B(+4.5%) |
| Sept 2017 | - | $274.67 M(+5.2%) | $1.03 B(+4.6%) |
| June 2017 | - | $261.14 M(+2.9%) | $979.98 M(+1.3%) |
| Mar 2017 | - | $253.74 M(+7.5%) | $967.36 M(+6.6%) |
| Dec 2016 | $907.23 M(+23.0%) | $235.94 M(+3.0%) | $907.23 M(+6.6%) |
| Sept 2016 | - | $229.16 M(-7.8%) | $851.18 M(+6.9%) |
| June 2016 | - | $248.51 M(+28.4%) | $796.02 M(+4.8%) |
| Mar 2016 | - | $193.62 M(+7.6%) | $759.58 M(+2.9%) |
| Dec 2015 | $737.89 M(+17.7%) | $179.89 M(+3.4%) | $737.89 M(-1.6%) |
| Sept 2015 | - | $174.00 M(-18.0%) | $749.74 M(+3.8%) |
| June 2015 | - | $212.07 M(+23.4%) | $722.37 M(+7.7%) |
| Mar 2015 | - | $171.92 M(-10.3%) | $670.88 M(+6.9%) |
| Dec 2014 | $627.02 M(+36.3%) | $191.75 M(+30.8%) | $627.69 M(+11.0%) |
| Sept 2014 | - | $146.63 M(-8.7%) | $565.54 M(+7.2%) |
| June 2014 | - | $160.58 M(+24.7%) | $527.74 M(+9.6%) |
| Mar 2014 | - | $128.74 M(-0.7%) | $481.40 M(+4.6%) |
| Dec 2013 | $460.09 M | $129.60 M(+19.1%) | $460.09 M(+5.6%) |
| Sept 2013 | - | $108.82 M(-4.7%) | $435.90 M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | $114.24 M(+6.3%) | $430.57 M(+3.3%) |
| Mar 2013 | - | $107.43 M(+1.9%) | $416.78 M(+1.9%) |
| Dec 2012 | $408.89 M(+14.4%) | $105.41 M(+1.8%) | $408.89 M(+4.9%) |
| Sept 2012 | - | $103.50 M(+3.0%) | $389.81 M(+3.3%) |
| June 2012 | - | $100.44 M(+0.9%) | $377.30 M(+2.5%) |
| Mar 2012 | - | $99.54 M(+15.3%) | $368.22 M(+3.0%) |
| Dec 2011 | $357.33 M(+16.8%) | $86.33 M(-5.1%) | $357.33 M(+1.5%) |
| Sept 2011 | - | $90.98 M(-0.4%) | $352.15 M(+3.3%) |
| June 2011 | - | $91.37 M(+3.1%) | $340.92 M(+4.2%) |
| Mar 2011 | - | $88.66 M(+9.3%) | $327.10 M(+6.9%) |
| Dec 2010 | $305.98 M(+18.3%) | $81.14 M(+1.8%) | $305.98 M(+3.7%) |
| Sept 2010 | - | $79.75 M(+2.8%) | $295.19 M(+4.9%) |
| June 2010 | - | $77.55 M(+14.8%) | $281.28 M(+5.5%) |
| Mar 2010 | - | $67.54 M(-4.0%) | $266.67 M(+3.1%) |
| Dec 2009 | $258.75 M(+6.1%) | $70.35 M(+6.9%) | $258.75 M(-6.3%) |
| Sept 2009 | - | $65.84 M(+4.6%) | $276.00 M(+2.7%) |
| June 2009 | - | $62.94 M(+5.6%) | $268.75 M(+3.2%) |
| Mar 2009 | - | $59.62 M(-32.0%) | $260.39 M(+6.7%) |
| Dec 2008 | $243.98 M(+136.4%) | $87.61 M(+49.6%) | $243.98 M(+24.5%) |
| Sept 2008 | - | $58.58 M(+7.3%) | $196.00 M(+24.1%) |
| June 2008 | - | $54.58 M(+26.3%) | $157.97 M(+23.7%) |
| Mar 2008 | - | $43.21 M(+9.0%) | $127.71 M(+23.7%) |
| Dec 2007 | $103.22 M(+36.8%) | $39.63 M(+92.9%) | $103.22 M(+25.9%) |
| Sept 2007 | - | $20.55 M(-15.5%) | $82.00 M(-2.1%) |
| June 2007 | - | $24.33 M(+29.9%) | $83.77 M(+2.0%) |
| Mar 2007 | - | $18.72 M(+1.7%) | $82.10 M(+8.8%) |
| Dec 2006 | $75.47 M(+227.6%) | $18.40 M(-17.5%) | $75.47 M(+15.7%) |
| Sept 2006 | - | $22.32 M(-1.5%) | $65.21 M(+29.6%) |
| June 2006 | - | $22.66 M(+87.4%) | $50.31 M(+63.4%) |
| Mar 2006 | - | $12.09 M(+48.4%) | $30.80 M(+33.7%) |
| Dec 2005 | $23.04 M(+56.9%) | $8.15 M(+9.9%) | $23.04 M(-9.6%) |
| Sept 2005 | - | $7.42 M(+135.5%) | $25.48 M(+39.9%) |
| June 2005 | - | $3.15 M(-27.3%) | $18.21 M(-4.2%) |
| Mar 2005 | - | $4.33 M(-59.1%) | $19.02 M(+29.5%) |
| Dec 2004 | $14.69 M(+673.1%) | $10.59 M(+7154.8%) | $14.69 M(+258.6%) |
| Sept 2004 | - | $146.00 K(-96.3%) | $4.10 M(+3.7%) |
| June 2004 | - | $3.95 M(+14.1%) | $3.95 M(+14.1%) |
| Sept 2001 | - | $3.46 M(-23.4%) | $3.46 M(-75.2%) |
| Sept 2000 | - | $4.52 M(-2.1%) | $13.99 M(+4.6%) |
| June 2000 | - | $4.62 M(-4.8%) | $13.37 M(+16.7%) |
| Mar 2000 | - | $4.85 M(+24.4%) | $11.45 M(+33.3%) |
| Sept 1999 | - | $3.90 M(+44.4%) | $8.59 M(+83.1%) |
| June 1999 | - | $2.70 M(+35.6%) | $4.69 M(+135.6%) |
| Mar 1999 | - | $1.99 M | $1.99 M |
| Dec 1998 | $1.90 M | - | - |
FAQ
- What is BioMarin Pharmaceutical annual gross profit?
- What is the all time high annual gross profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual gross profit year-on-year change?
- What is BioMarin Pharmaceutical quarterly gross profit?
- What is the all time high quarterly gross profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly gross profit year-on-year change?
- What is BioMarin Pharmaceutical TTM gross profit?
- What is the all time high TTM gross profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM gross profit year-on-year change?
What is BioMarin Pharmaceutical annual gross profit?
The current annual gross profit of BMRN is $1.90 B
What is the all time high annual gross profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual gross profit is $1.90 B
What is BioMarin Pharmaceutical annual gross profit year-on-year change?
Over the past year, BMRN annual gross profit has changed by +$292.00 M (+18.11%)
What is BioMarin Pharmaceutical quarterly gross profit?
The current quarterly gross profit of BMRN is $557.28 M
What is the all time high quarterly gross profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly gross profit is $581.57 M
What is BioMarin Pharmaceutical quarterly gross profit year-on-year change?
Over the past year, BMRN quarterly gross profit has changed by +$31.80 M (+6.05%)
What is BioMarin Pharmaceutical TTM gross profit?
The current TTM gross profit of BMRN is $2.19 B
What is the all time high TTM gross profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM gross profit is $2.19 B
What is BioMarin Pharmaceutical TTM gross profit year-on-year change?
Over the past year, BMRN TTM gross profit has changed by +$283.62 M (+14.89%)